Long-term treatment with metformin is safe for preventing or delaying the development of type 2 diabetes….
Read More »SPECIAL FEATURE: Readers Respond to Dr. Richard Kahn’s Statement: “Diabetes Prevention is a Waste of Resources”
For Dr. Kahn’s comments and the Joslin Diabetes Center’s response, see our article in last week’s newsletter: Joslin Replies to Dr. Richard Kahn’s Statement: “Diabetes Prevention is a Waste of Resources.”
Read More »Joslin Replies to Dr. Richard Kahn’s Statement: “Diabetes Prevention is a Waste of Resources”
Physicians strongly disagree with statements made by former executive of the American Diabetes Association.…
Read More »Diabetes Prevention Program Can Deliver Modest Weight Loss
The U.S. Diabetes Prevention Program conducted a clinical trial in 2002 showing that modest weight loss through caloric restriction and increased physical activity reduced the incidence of diabetes in high-risk patients by 58%….
Read More »Family History Underused in Diabetes Prevention Efforts
Type 2 diabetes prevention programs aimed at high-risk individuals with a family history of the disease may underuse psychological and motivational strategies that emphasize genetic susceptibility.…
Read More »FDA Recommends Vytorin for CVD Prevention in Predialysis CKD Patients
An FDA advisory committee has recommended unanimously that the ezetimibe-simvastatin combination pill (Vytorin) be approved for prevention of cardiovascular disease in CKD patients who are not on dialysis.…
Read More »Early Metformin Therapy Delayed Onset, and Prevention of PCOS
Recent data suggest that treatment with metformin during late childhood or early puberty may impede or prevent the development of polycystic ovary syndrome in girls at high risk for the disease.…
Read More »Adapting the Diabetes Prevention Program for Native American Youth
This study (299-OR) explored ways to modify the Diabetes Prevention Program (DPP) lifestyle change program to make it culturally and age appropriate for Native American youth.…
Read More »Study Shows Promise for Developing Protein Therapies for Disease Prevention
A computer analysis by two University of Michigan researchers shows promise for helping develop therapies for some major diseases by rescuing proteins that have stopped performing normally….
Read More »PRADAXA (DABAGATRAN), A New Anticoagulant for Stroke and Embolism Prevention
By Jennifer Freidman 2011 Doctor of Pharmacy Candidate, University of Florida Atrial fibrillation currently affects about 2.2 million Americans. If left untreated it can cause embolism and stroke. The American Heart Association’s current recommendations for stroke prevention include anticoagulation therapy with warfarin being the agent of choice. Warfarin is a drug with a …
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.